Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes.
AUTOR(ES)
Li, Q
RESUMO
Infection of B lymphocytes by Epstein-Barr virus (EBV) requires attachment of virus via binding of viral glycoprotein gp350 to CD21 on the cell surface. Penetration of the cell membrane additionally involves a complex of three glycoproteins, gH, gL, and gp42. Glycoprotein gp42 binds to HLA-DR. Interference with this interaction with a soluble form of gp42, with a monoclonal antibody (MAb) to gp42, or with a MAb to HLA-DR inhibited virus infection. It was not possible to superinfect cells that failed to express HLA-DR unless expression was restored by transfection or creation of hybrid cell lines with complementing deficiencies in expression of HLA class II. HLA class II molecules thus serve as cofactors for infection of human B cells.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=191687Documentos Relacionados
- Epstein-Barr virus vectors for gene delivery to B lymphocytes.
- Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes.
- Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.
- Epstein-Barr virus DNA is amplified in transformed lymphocytes.
- Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes.